Profile cover photo
Profile photo
John Garner
John Garner's posts

Post has attachment
PLA-amine from PolySciTech used in development of atherosclerosis-targeted nanoparticles for treatment of heart disease
disease, typically due to atherosclerotic lesions, is one of the leading causes
of death in USA. Most treatments for this disease focus on surgical interventions
(e.g. stent placement), which is often utilized in acute situations, or on
systemic medic...

Post has attachment
Protein phosphorylation assay kits by Tymora Analytical now available through PolySciTech
selective phosphorylation of proteins is a key step in many pathways regulating
their functions. Abnormal phosphorylation is involved in a wide variety of
diseases including cancer. To perform antibody labeling, an effective antibody
has to be made for ...

Post has attachment
CRS Meetin 2017
Meet PolySciTech ( at booth 501 at the CRS meeting in Boston next week

Post has attachment
PLGA from PolySciTech used in the development of nanoparticle-based obesity treatment
Obesity in
humans is a contributing factor to many other health concerns, such as
arthritis and cardiovascular problems. Recently, researchers at Purdue
University utilized PLGA from PolySciTech ( ) (PolyVivo AP101) to develop

Post has attachment
Tissue scaffolds with improved delivery of growth factor developed using PLGA-PEG-Mal from PolySciTech
A powerful
tool in medicine would be the ability to produce a tissue-scaffold which allows
for tissue which has been lost due to disease or trauma to be replaced with
fresh stem-cells. There are many barriers to the developemtn of this tool one
of which is ...

Post has attachment
mPEG-PLGA from PolySciTech used in development of immune-control treatment for allergic reactions
contact dermatitis is a common inflammatory skin condition caused by a
pathological immune response to a given trigger such as poison ivy oils or
nickel metal. This aggravating skin condition can be prevented and treated by
reducing the local forma...

Post has attachment
mPEG-PLGA from PolyScitech used in development of dual-drug nanotherapy treatment for non-small cell lung cancer
cell lung cancer is an extremely prevelant type of cancer with over 200K cases
in the USA per year. Typically it is treated using chemotherapy and
radiotherapy, but the incidence of reoccurrence is quite high after these
therapies. Recently, resea...

Post has attachment
Immunotherapy research using PLGA, PLGA-PEG-maleimide, and PLGA-rhodamine from PolySciTech shows promise for cancer treatment
of cancer remains difficult due to a wide variety of reasons. One problem is
that, typically, cancer tends to metastasize and spread so that there are
smaller tumors, tendrils or clumps of tumor cells instead of a singular, lone
cancer tumor. Thes...

Post has attachment
PolySciTech certificates of analysis now available directly on the website
All materials generated by the PolySciTech division of Akina, Inc. ( ) undergo a rigorous
set of chemical characterization tests. These typically include
Fourier-transform infrared spectrophotometry (FTIR) scan, proton nuclear
magnetic r...

Post has attachment
Synthesize like a pro with reactive intermediates generated by award-winning researchers
Pharmaceuticals, a Purdue University spin-off company, has won several awards including
the Purdue Ag-celerator award, award, as well as has been a
finalist in the MassChallenge Boston competition. This company, founded by Sherine
Wait while more posts are being loaded